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ABSTRACT 
Conjugated GNPs were synthesized  by one step reaction of AuCl4
-
 with   cefotaxim  (CFX) and its Schiff base derivative 
with 4-N,N-dimethylamino benzaldehyde [sodium 3-(acetoxymethyl)-7-((2Z)-2-(2-(4-dimethylamino) benzylideneamino) 
thiazol-4-yl)-2-(methoxyimino) acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate] (SCFX)without the 
need of  reducing and functionalizing agents. The reduction process was monitored by uv-visible spectrophotometry  and 
the synthesized GNPs were characterized by TEM, SEM, AFM and  XRD analysis. The conjugation of GNPs with the two 
ligands was characterized by FTIR spectrophotometry. The size, morphology, and stability of GNPs were varied with 
concentration ratio of ligand/Au(III), pH medium and reaction temperature 
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INTRODUCTION 
Several methods  have been reported  to conjugate anti-biotics with GNPs [1-6].Highly surface area of nanoparticles 
increases drug density on the surface and allows higher concentrations of drug or multiple drugs  loaded on single 
particles [7, 8] .The Synthesis of GNPs can be proceeded in a one-step reaction  where  the antibiotic act as a reducing  
and functionalizing agent  to afford the antibiotic- functionalized nanomaterial without using any  linkers [4-6]. 
Cepalosporins are β-   lactam antibiotics which are based upon the four-membered nitrogen-containing beta-lactam ring 
that gives these agents their antibacterial activity.  Stable GNPs were synthesized by one step reaction using different  
cephalosporin antibiotics such as  cephalexin , cefaclor, [3] ciproflaxin [1], and ceftriaxone[1] as a stabilizing agents in 
presence of reducing agent. As aprimary amine group carriers, some of these drugs  acted as both reducing and capping 
agent for the synthesis of gold nanoparticles[1-3,7].Accordingly, condensation of the free amino group of β-lactam 
antibiotics  with different carbonyl compounds  to form Schiff  bases  may  inhibit the reduction of Au(III) ions.In this paper, 
we describe a single one pot synthesis of  gold nanoparticles using the β-lactam antibiotic, cefotaxim,  (CFX)  compared 
with its  Schiff base derivative  [sodium 3-(acetoxymethyl)-7-((2Z)-2-(2-(4-dimethylamino) benzylideneamino) thiazol-4-yl)-
2-(methoxyimino) acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate] (SCFX)in aqueous solutions 
without the addition of reducing ordispersing agents.  
 
 
 
 
 
 
 
The reduction process was pursued by uv-visible spectrophotometry   at different conditionslike  concentration ratio of 
reactants,  pH and temperature. The synthesized GNPs were characterized by uv-visible spectrophotometry, transmission 
electron microscopy (TEM), scanning electron microscopy (SEM), atomic force microscopy(AFM) and by X-ray diffraction 
(XRD) analysis 
2.EXPERIMENTAL 
2.1. Instrumentation 
Electronic spectra in the (UV-Visible) region (200-1100) nm were recorded on SHIMADZU   1650 UV-Visible 
spectrophotometer. FTIR spectra were recorded on   Shimadzu  FT-IR 8400S Fourier transform  using KBr and CsI discs. 
TEM images were acquired using Philips CM10 Transmission electron microscope. Samples for TEM studies were 
prepared by placing a drop of the gold colloidal solution on a carbon coated copper grid which was driedunder vacuum.  
SEM images were acquired using TE SCAN VEGA III, Czech. Scanning electron microscope.AFM  images were acquired 
using AFM model AA 3000 SPM 220 V-Angstrum  Advanced INC. USA. Samples were prepared by applying few drops 
GNP solutions on a glass slide and a thin layer was formed as uniform as possible followed by vacuum drying. X-Ray 
diffraction (XRD)  measurements were performed using a Shimadzu XRD-6000 x-ray diffraction spectrometer. All GNPs 
solutions were dialyzed prior to analysis by using a cellulose tube (MW cutoff 12 400 D) against 1 L of DDW for 9 h at 30 
°C.  Separation of nanoparticles was achieved  by centrifugation CENTERFUGE  C 41 7800   14000 r.p.m., Jouan, 
(France). 
2.2. Materials and methods 
All  the following chemicals were  of analytical grades and were used as received from suppliers : Cefotaxime 
Sodium C16H16N5O7S2Na GMBH,sodium chloroauratedihydrate NaAuCl4.2H2O (Analar BDH),potassium hydrogen 
phthalate2-(HO2C)C6H4CO2K, 99.95% (BDH),potassium chloride, potassium dihydrogen orthophosphate KH2PO4, and 
dipotassium hydrogen orthophosphate 99% (Analar). The Schiff base  ligandSCFXwas prepared before and  the structural 
characterization of the compound wasreported in our previous work [8]. Standard solutions of cefotaxime sodium salt 
(C16H16N5O7S2Na, 2×10
-4
 M), and SCFX (1.6×10
-3 
M)  werepreparedbydissolving0.1000gof  each   reactant  in 
100mLdeionized water(DDW)in100mL volumetricflasktogivetheantibiotic stock solution. Then 10mLofthe stocksolution was 
diluted to100mL  with(DDW) ina 100mLvolumetricflask.A stock aqueous solution ofAuCl4
-
(5×10
-3
  M) was prepared by 
dissolving 0.1000 g  of  NaAuCl4.2H2O in 50 mL DDW in a volumetric flask. A standard solution  of AuCl4
-
 (5×10
-4
  M)  
which contains (2.5×10
-4
 M)  of  Au
3+
  ions,  was prepared by diluting 10 mL  of the stock solution to 100 ml with (DDW).  
Synthesis of gold nanoparticle conjugates  
To different volumes of  AuCl4
-
 standard solutions (5×10
-4
 M) : (  0.25 ,0.5 , 0.75 , 1.0, 1.25 , 1.5 , 2.0 , 2.5 , 3.0, and 3.5 
mL) in  ten 5 mL volumetric flasks  were added one mL aliquots of standard solution (2 and 1.6×10
-4
 M)  of  each of  
cefotaxime  andSCFX respectively with continuous stirring.  The volumes were then completed to 5 mL  by DDW, and the 
absorbance of each solution was measured at room  temperature at different time intervals.  To study the effect of pH the 
synthesis of  GNps was carried out  at different  pH  (2.4, 2.89 ,3.84,4.85, 5.8, 6.92, 7.55,8.92, 9.9,10.9, 11.9). To study 
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the  effect  of temperature on the synthesis of  GNPs by each ligand each set of solutions was heated for 5 minutes at (30, 
40, 50, 60, 70 and 80 ºC) for 5 min, in water bath with continuous stirring.  The effect of  heating periods  on the synthesis 
rate of GNPs were studied  by heating each sample at the selectedtemperature for ( 5, 10, 15, 20, 25,30, 45, 60) min. 
3. RESULTS AND DISCUSSION 
The UV–visible spectra  of  cefotaxime (CFX),  SCFX  and AuCl4
-
  solutions as well as GNP solutions prepared  
from mixing equal volumes of standard  aqueous solutions  of AuCl4
-
 (III) with each  ligand  at room temperature  are 
shown in (Figure 1). The spectrum of AuCl4
-
 solution exhibited a high intensity band at λ 240 nm and with a shoulder λ 290 
nm assigned to LMCT transitions of tetrachloroaurate complex [9,10].  The spectrum of  the (CFX) antibiotic (Figure 1A)) 
displayed a multiplet covering the uv region at wavelength range 200-300 nm with three absorption maxima at λ 238, 259 
and 297 nm assigned to the π→π* transition [11].  The spectrum of  SCFX in DDW (Figure 1B) displayed a multiplet band 
with three absorption peaks located at λ max  235, 295, and 342nm attributed to the π→π* transition  and  a low intensity 
band observed at λ max 430 nm refers to the n→π* transition[11].The solution mixtures of AuCl4
-
 with the two ligands 
showed pink red colors and their spectra exhibited single absorption bands at λ max 531and 532 nm respectively, indicating 
the reduction of AuCl4
−
by the two ligands to form GNPs. The time required for the development of  the pink color was 2 
and  and 3.5 h for SCFX andCFX respectively  
 
 
 
 
 
 
 
 
 
 
Figure 1. The UV-visible spectra  and images of a- cefotaxime b- AuCl4
-
 and c-synthesized gold nanoparticle in 
aqueous solutions after 24 h.   
No additional bands were observed in the visible or NIR region which refers to the formation of spherical gold 
nanoparticles[12-20]. The proposed mechanism  suggests that  formation of GNPs may  have proceeded  through  the 
oxidation  of  the  amine of  the aromatic thiazole ring  from  which the formed electrons go on to reduce the auric(III) ions 
to gold atoms according to the literature[21,22]. Cefotaxim molecules contain many active groups such as amino, amido, 
thio and carboxyl groups, which react easily with GNPs by chelation [23]. Furthermore, Cefotaxime  molecules 
themselves, like many beta lactam drugs, can bind each other through van der Waals interaction and hydrogen bonding 
[24]. Ultimately, assemblies are made up of nanogold cores and the surrounding cefotaxime molecules. The higher 
capability of the  Schiff  base ligands  SCFX  to reduce the Au(III) ions to GNPs  compared with CFX indicatesthe 
presence of additional site for electron donation  or for further stabilization of GNPs like the azomethinegroup.It also 
proves that  the reduction process by (CFX)  is not attributed to amino  group of thiazole ring only, but  other electron 
donor sites at the beta lactam ring, amide group moiety as well as thio and carboxyl groups, at the thiazine ring are 
involved  in the reduction process  and chelation with GNPs[25]. 
3.1. Characterization of prepared gold nanoparticles 
The size, morphology  and surfaces of the synthesized gold nanoparticles were investigated by SEM, TEM and AFM 
analysis  of GNPs. The TEM  analysis  of the  cefotaxime conjugated GNPs showed that the particles were spherical in 
shape with smooth surface morphology and mono-dispersed in nature with narrow size distribution  and mean size 
diameters of around 17 nm (Figures2).The SEM images and size distribution  for  cefotaxime and  SCFX conjugated 
GNPs (Figures3 and 4 respectively) showed spherical nanoparticleswith average size diameters around 60 and 27 nm 
respectively which indicates the difference in stabilizing effect   between the two  ligands. However  the  AFM images 
(Figures5 a and b respectively) showed the opposite  result as the GNPs were spherical in shape and the average particle 
diameters were  around 56 and 66  nm, respectively, which may be attributed to different sample preparation conditions 
that caused the formation of agglomerates.  
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Figure2. TEM image and particle size distribution for CFX- GNPs conjugates. 
 
 
 
 
 
 
 
 
 
 
Figure 3.a-SEM image b-particle size distribution of the cefotaxime- synthesized GNPs (average particle size 
diameter= 60 nm) 
 
Figure4.a-SEM image b- cross section image  and  c-particle size distribution of the SCFX synthesized GNPs with 
an average size diameter 27 nm 
 
 
 
 
 
 
 
 
 
 
 
Figure 5a.AFM images  andparticle size distribution charts of the cefotaxime--synthesized GNPs with an average 
diameter around 56.47 
 
a 
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Figure 5b.AFM images  andparticle size distribution charts of the SCFX- synthesized GNPs with an average 
diameter around 66.17 nm 
The XRD patterns of GNPs synthesized by cefotaxime and SCFXareshown in (Figures 6a and b)), respectively. 
Two diffraction peaks were observedat 2θ = (38.0547, 44.531), and (38.077, 44.42) degrees for the two samples 
respectively corresponding to the planes (111) and (200) of  facecentered cubic (fcc) Au metal crystal lattice [12,19,26]. 
 
 
 
 
 
 
 
 
 
 
Figure 6. XRD spectrum of a-cefotaxime- , and b-SCFX- synthesized GNPs. 
The FTIR spectra of CFX and CFX-capped GNPs are shown in (Figures (7a and b). respectively.The spectrum of GNPs 
exhibited   the  shifts of  the  two bands attributed to the νas(N–H) and νs (N–H) vibrations of  NH2 which were located at  υ 
3348 and 3252cm
−1
  respectively of  freeCFX[11, 27-29] were shifted to lower wavenumbers at 3250 and 3285 cm
-
1
respectively 
The FTIR spectra of CFX showed that the bands  assigned  to the stretching  vibrations of  carbonyl groups of  β-lactam 
ring , the overlapped amide and ester carbonyls  carboxylate (C=O) groups located at 1750, 1647 [30] and 1728cm
-
1
[31,32] respectively  were  shifted to 1743, and 1721 cm
-1
 respectively. The bands at 1612, 1388 cm
-1
 corresponding to 
the carboxylate asymmetrical and symmetrical stretching modes [28,30,33]  were shifted to 1635 and 1364 cm
-1
 
respectively while the band  assigned  to υ(C–S) vibrations of  the six membered thiazene ring of  free CFX  at (593) cm
-1
[ 
35]was shifted to 570cm
-1
. The FTIR spectrum of  SCFX- synthesized GNPs shown in Figures (7 c and d)) respectively 
displayed  shifts  of   bands attributed to the stretching vibration of  both β-lactam ring carbonyl groups and amide carbonyl 
groups as well as  C-S group observed at 1744, 1656  and 580 cm-
1
 respectively in the  spectrum of the free ligand [27, 
29, 30, 35,36] to higher wavenumbers  at 1760 ,1732 and 592 cm
-1
 respectively. The bands assigned to the asymmetric 
and symmetric stretching vibration, respectively of carboxylate anion, located at (1621) and (1377) cm
-1
 [29,33]were 
observed at υ1621 and 1370 cm
-1 
respectively, while the band attributed to the azomethine group remained in its position  
at 1643cm-
1
 [29,38]. These   observations confirm the conjugation  of GNPs by CFX and SCFX molecules 
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Figure7.FTIR spectra of (a)-CFX  (b)-CFX-capped GNPs (c)-SCFXand (d) - SCFX-- capped GNPs. 
 
3.2. Concentration effect 
Figures 8(a and b) show  the  variation  of  intensity and position of  surface plasmon band SPB of  gold nanoparticles  
solutions   prepared  from   adding  a fixed volume (1ml) of cefotaxime  standard  solution (2×10
-4
  M) to different  volumes 
of  AuCl4
-
 standard solutions and  diluted to 5ml.The concentration ratio of CTX/ Au(III) ions in  the resulting solution 
mixtures  are: 3.2, 1.6, 1.067, 0.8, 0.64, 0.533, 0.4, 0.32, 0.267, 0.229respectively (samples 1-10 respectively). At highest 
concentration ratio of CTX/ Au(III) (3.2, sample 1)  no synthesis of  GNPs was  observed even after 24h as the  solution 
remained  colorlessand the spectrum exhibited only  the weak absorption bandsof  the original antibiotic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.Absorption spectra of  CFX -capped GNP at different concentrations of gold ion after 24 h 
 
At concentration ratios 1.6-0.4  ( samples 2-7) the  colors  of  solutions  turned  ruby  pink  to  purple within 2-3 h and their 
spectra showed  increased   intensity of  a single  absorption band  observed  at 520- 535 nm  assigned to surface 
plasmon resonance of spherical GNp with an estimated particle size of  38-60  nm diameter [13-15] At lower concentration 
ratio of  CTX/ Au(III) (0.32, 0.267 and 0.229,  samples 8-10 respectively) the colors of solutions were dark violet  and their 
spectra  displayed two absorption bands,  a broad low intensity  band  which appeared at  longer  wavelength range λ 
544-556 nm  and  another band  at λ 680, 921 nm  respectively  which refers to   the formation  of  non-sphericalGNPs 
aggregates or gold nanorods[17,19,26,38].  The colloid  of  CTX/ Au(III) 0.64( solution 5, Figure9a)  was stable for up to 60 
days without significant changes in the position of SPB. The second colloid of CTX/ Au(III)  0.32 (sample 8, Figure 
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(9b))showed a gradual shifts in the positions of  both bands with time,then the colloid remained stable for one  month. 
These resultsrefer to the protection and stabilization of GNPs by CFX. 
 
 
Figure 9.Absorption spectra of CFX-capped GNPs prepared from  solutions containing a concentration ratio of 
CFX/Au (III) = 0.64 (sample 5)(a) and  0.32 (sample 8)(b) after 24 h and  four weeksand 60 days  
Figures (10 a and b) show the  variation  of  intensity and position of  SPB of  gold nanoparticles  solutions   
prepared  from   adding  a fixed volume  of  SCFX  standard  solution (1.6×10
-4
  M)  to different volumes of AuCl4
-
 standard 
solutions.  The concentration ratios of SCFX /Au (III)in these samples were:2.56, 1.28, 0.85, 0.64, 0.512, 0.43, 0.32, 
0.256, 0.213 and 0.183 (samples 1-10).  The highest concentration ratios 2.56 and 1.28 (samples 1 and 2 respectively) 
showed no reduction of Au(III) ions as the resulting solutions remained colorless and no SPBs were observed in their 
spectrafor 48 h. At  lower concentration ratios (0.85, 0.64, 0.512, 0.43, samples 3-6 respectively), the  colors  of  solutions  
became ruby   pink  to  purple  within 2 h and their spectra  showed a single   SPB  appeared   at   wavelength range  517- 
533 nm  related to  spherical GNp with estimated particle size range 32-56 nm diameter[13-15]. 
 
 
 
 
 
 
 
 
 
 
Figure 10. Absorption spectra of GNP at different concentrations ratio of SCFX /Au(III) after 24 h : a-samples(1-6) , 
b-samples (7-10). 
The spectrum of sample 4 (SCFX/Au(III) = 0.64) (Figure ( 11a)  shows that maximum absorption of SPB was achieved 
after 4 weeks then the  solution remained  stable  in the wavelength range 530-532 nm for 2 months. This indicates that 
GNPs have been capped and stabilized by SCFX. At concentration ratio 0.32 (sample 7) the SPB became broader and its 
position was shifted to longer wavelength (544 nm) which refers to formation of   larger particle sizes (85-86) nm diameter 
[13-15] as a result of aggregation. At concentration ratios  0.256, 0.213  ( samples 8 and 9 respectively) the solutions were 
of dark violet colors  and their spectra  displayed  a broad   low  intensity  band  at  wave length range 554 and 569 nm 
respectively  and  another band  at  740  and 1000 nm  respectively  which refers to   the formation  of  non spherical 
GNPs aggregates or  gold nanorods  [17,18,26,38].  The spectrum of sample 9 (Figure 11 b [SCFX]/[Au(III)] = 0.213) 
exhibited simultaneous hypsochromic shift of the transverse plasmon band and increase in the longitudinal/transverse 
band ratio with time which reached its maximum value after 25 days. After two months, the solution showed  
hypsochromic shifts decreased intensity of both bands.   At the lowest ratio of [SCFX]/[Au(III)]  (0.183, sample 10) the 
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colors of solutions were pale yellow and the  resulting spectrum showed the absorption bands of AuCl4
-
 which refers to  
incomplete or no reduction of  Au(III) by SCFX at this ratio  These results show that the concentration ratio of CTX / Au(III) 
and ([SCFX]/[Au(III)] played an important role in controlling both size and morphology of the synthesized GNps. 
 
Figure 11. Absorption spectra of  SCFX – conjugated GNPs containing a concentration ratio of SCFX /Au (III) = 
0.64 (sample 4) and 0.213 ( sample 9) after24h,  25 days  and 64 days. 
3.3. pH Effect: 
Synthesis of GNPs by CFX  andSCFX was conducted using the optimum concentration ratio of CFX/Au (III) 
(0.64)at different pH media.The progress of reaction was  monitored by UV-visible spectrophotometry as is  shown in 
(Figures 12 and 13) respectively. The development of pink color as well absorption maxima of surface  plasmon band 
(SPB) using CFX were only observed at pH = 3.84  after 3h. The solution exhibited one SPB at 525 nm characteristic of 
spherical GNPs [12,16-18,39]with estimated size diameter 30-40 nm [37]. 
 
 
 
 
 
 
 
 
 
 
 
Figure 12.  Absorption spectra   and images of CFX synthesized GNPs solutions in  different pH media  at room 
temperature after 24 h. 
After 24h the position of SPB was shifted to 532-536 nm. The colloid was stable for almost two weeks.  Changes 
in colors and spectra were also observed  at pH 2.4, 2.89 and 4.85  (Figure (12)) while still no color changes occurred at 
higher pH values.At pH = 2.89 the solution showed a violet color and the spectrum of  this colloid showed two absorption 
bands appeared at 536 nm and 1057 nm referring to the formation of non-sphericalGNp(nanorods) [17,26,38](Figures 
(12)).Figure  13 shows the UV-visible spectra of  GNPs  synthesized by SCFXat  different pH range (2.4- 11.86). After 3h  
solution of pH = 2.89, 3.84, 4.85 and 5.80gave  changes in colors after 3h and  their absorption spectra  exhibited the 
bands assigned to SPR of  spherical GNPs at λ 560, 533, 555 and  555 respectively nm. This indicates that the reduction 
of Au(III) ions by SCFX  can be achieved at wider pH range.  The solutions were stable for more than 1 week which refers 
to protection of GNPs by the ligand molecules. At pH = 4.85 the color of solution was violet and its spectrum exhibited one 
SPB at 555 nm characteristic of spherical GNPs[12,16-18,39,40]with estimated GNP diameter 60-80 nm [39] . After 24h, 
the spectrum exhibited gradual shifts of the band position to shorter wavelength (530-535 nm) with a gradual appearance 
of additional absorption band appeared λ 720-730 nm referring to the formation of elongated GNPs. The above mentioned 
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results show that the variation of pH plays has an important effect on the rate of Au (III) ions reduction by the CFX and 
SCFX to GNPs as well as on the size and morphology of GNPs which  may be attributed to the difference in  acid- base 
behavior of the functional groups present in the skeleton of the two  molecules. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Variation of surface plasmonresonance bands of SCFX- synthesized GNPs prepared in  different pH 
media at room temperature after 24h. 
3.4. Temperature effect 
Figures 14and15 show respectively the progress GNPs synthesis and color change images with time  for  solution 
mixtures containing equal volumes of CFX and SCFXwithAu(III) standard solutions at  temperature range 20-80 °C  
monitored by  uv-visible spectroscopy. At 20°C  the reduction  process of  Au(III)  by both  ligands was considerably slow 
and the  pink color  was  detected after  several hours.  Gradual increaseofheating  temperature up to 80°C caused  
increased rates  of  GNPs formation accompanied with increased amplitude  of  SPBs . This indicates  that increased 
reaction temperature enhancedthe reduction process,and the  growth of nanoparticles as a result of  high rate of 
nucleation [41]. 
The reduction progress with  temperature led to bathochromic shifts  of SPBs  without changing the profile  of  these 
bands. The optimum  heating temperature for production of more stabilized  GNPs solutions  by CFX and SCFX with time  
was 40 °C  for 15 and 10 min  respectively. Despite the high rate of GNPS synthesis at  (70 and 80 °C) the resulting 
colloids showed gradual formation of sediments with time . This may be attributed to the desorption or catalytic 
decomposition of the capping ligand which leads to further aggregations of GNPs. The above mentioned results showed 
the importance of temperature as an additional controlling factor on the particle sizes and stability of the studied GNPs 
solutions.  
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Figure14.    Spectral changes and images of CFX- synthesized spherical GNPs at 20- 80 °C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15.Spectral  changes  andimages of SCFX-synthesized GNPs  solutions prepared at  20- 80 
◦ 
C    
 
CONCLUSIONS 
Gold nanoparticles have been successfully produced by a  simple wet chemical reduction  of AuCl4
-
 in aqueous solutions 
using  cefotaxime  antibiotic, and  the cefotaxime Schiff  base SCFX without the use of other reducing or dispersing 
agents. Morphology and sizes of the synthesized gold nanoparticles for the studied ligands were detected from the 
positions and extinction of surface plasmon bands monitored by UV-visible spectrophotometry and confirmed by SEM, 
TEM and AFM analysis. Conjugation of  GNPs by the two ligands was confirmed  by FTIR spectroscopy. The shape, size 
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of GNPs and enhancement of GNPs synthesis are controlled by reactant and its concentrations, pH, temperature and 
heating time intervals. The higher synthesis rates  of  GNPs  by the Schiff  base ligand  suggested that oxidation  of  amino 
group was not totally responsible for the reduction of Au(III) ion,  but  may be  further attributed to the oxidation of  the 
lactam ring, ,thiazine ring groups, carboxylate anion as well as azomethine group of the Schiff base ligand .  
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